Mostrar el registro sencillo del ítem

dc.contributor.author
Blanco, Eduardo  
dc.contributor.author
Galeano, Pablo  
dc.contributor.author
Palomino, Ana  
dc.contributor.author
Pavon, Francisco J.  
dc.contributor.author
Rivera, Patricia  
dc.contributor.author
Serrano, Antonia  
dc.contributor.author
Alen, Francisco  
dc.contributor.author
Rubio, Leticia  
dc.contributor.author
Vargas, Antonio  
dc.contributor.author
Castilla-Ortega, Estela  
dc.contributor.author
Decara, Juan  
dc.contributor.author
Bilbao, Ainhoa  
dc.contributor.author
Rodríguez de Fonseca, Fernando  
dc.contributor.author
Suaréz, Juan  
dc.date.available
2017-07-18T21:00:43Z  
dc.date.issued
2016-03  
dc.identifier.citation
Blanco, Eduardo; Galeano, Pablo; Palomino, Ana; Pavon, Francisco J.; Rivera, Patricia; et al.; Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus; Elsevier Inc; European Neuropsychofarmacology; 26; 3; 3-2016; 477-492  
dc.identifier.issn
0924-977X  
dc.identifier.uri
http://hdl.handle.net/11336/20867  
dc.description.abstract
In the reward mesocorticolimbic circuits, the glutamatergic and endocannabinoid systems are implicated in neurobiological mechanisms underlying cocaine addiction. However, the involvement of both systems in the hippocampus, a critical region to process relational information relevant for encoding drug-associated memories, in cocaine-related behaviors remains unknown. In the present work, we studied whether the hippocampal gene/protein expression of relevant glutamate signaling components, including glutamate-synthesizing enzymes and metabotropic and ionotropic receptors, and the hippocampal gene/protein expression of cannabinoid type 1 (CB1) receptor and endocannabinoid metabolic enzymes were altered following acute and/or repeated cocaine administration resulting in conditioned locomotion and locomotor sensitization. Results showed that acute cocaine administration induced an overall down-regulation of glutamate-related gene expression and, specifically, a low phosphorylation level of GluA1. In contrast, locomotor sensitization to cocaine produced an up-regulation of several glutamate receptor-related genes and, specifically, an increased protein expression of the GluN1 receptor subunit. Regarding the endocannabinoid system, acute and repeated cocaine administration were associated with an increased gene/protein expression of CB1 receptors and a decreased gene/protein expression of the endocannabinoid-synthesis enzymes N-acyl phosphatidylethanolamine D (NAPE-PLD) and diacylglycerol lipase alpha (DAGLα). These changes resulted in an overall decrease in endocannabinoid synthesis/degradation ratios, especially NAPE-PLD/fatty acid amide hydrolase and DAGLα/monoacylglycerol lipase, suggesting a reduced endocannabinoid production associated with a compensatory up-regulation of CB1 receptor. Overall, these findings suggest that repeated cocaine administration resulting in locomotor sensitization induces a down-regulation of the endocannabinoid signaling that could contribute to the specifically increased GluN1 expression observed in the hippocampus of cocaine-sensitized mice.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier Inc  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Cocaine  
dc.subject
Conditioned Locomotion  
dc.subject
Cocaine Sensitization  
dc.subject
Cannabinoid  
dc.subject
Glutamate  
dc.subject
Hippocampus  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-06-12T21:00:21Z  
dc.identifier.eissn
1873-7862  
dc.journal.volume
26  
dc.journal.number
3  
dc.journal.pagination
477-492  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Blanco, Eduardo. Universidad de Málaga; España. Universidad de Lleida; España  
dc.description.fil
Fil: Galeano, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina  
dc.description.fil
Fil: Palomino, Ana. Universidad de Málaga; España  
dc.description.fil
Fil: Pavon, Francisco J.. Universidad de Málaga; España  
dc.description.fil
Fil: Rivera, Patricia. Universidad de Málaga; España  
dc.description.fil
Fil: Serrano, Antonia. Universidad de Málaga; España  
dc.description.fil
Fil: Alen, Francisco. Universidad de Málaga; España  
dc.description.fil
Fil: Rubio, Leticia. Universidad de Málaga; España  
dc.description.fil
Fil: Vargas, Antonio. Universidad de Málaga; España  
dc.description.fil
Fil: Castilla-Ortega, Estela. Universidad de Málaga; España  
dc.description.fil
Fil: Decara, Juan. Universidad de Málaga; España  
dc.description.fil
Fil: Bilbao, Ainhoa. Universidad de Málaga; España  
dc.description.fil
Fil: Rodríguez de Fonseca, Fernando. Universidad de Málaga; España  
dc.description.fil
Fil: Suaréz, Juan. Universidad de Málaga; España  
dc.journal.title
European Neuropsychofarmacology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0924977X15004307  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/j.euroneuro.2015.12.040